Flags theoretical pathologic angiogenesis potential: PMC12446177 Evidence Summary Preclinical: IBD/colitis models: High remission rates, restored mucosal architecture, improved barrier function Tendon repair: Accelerated healing, improved tensile strength, reduced fibrosis Neurovascular: Sciatic nerve protection, enhanced blood vessel growth in nerve tissue Human data (emerging): Interstitial cystitis pilot (2024, n=12): 10/12 complete resolution, 2/12 at 80% improvement IV safety study (2025, n=2): no adverse effects on cardiac, hepatic, renal, or glucose biomarkers Knee pain retrospective (2021, n=17): 91.6% reported significant improvement No large-scale controlled trials published Safety: No immunosuppression or hormonal disruption in available data 2025 systematic review (HSS Journal): recommends caution due to limited high-quality clinical evidence 2025 narrative review: flags theoretical pathologic angiogenesis risk Stable in gastric acid (oral administration viable) No observed toxicity at therapeutic doses in published reports Foundational Reviews Sikiric P, Seiwerth S, et al
Reconstitute one vial at a time (every 2 days) to keep solutions fresh
I would welcome feedback on this as I am unsure but want a balanced approach to the life changes I need to make
Further research is required to clarify its role in humans
Semax is a synthetic neuropeptide that has been investigated in experimental and laboratory models for its potential involvement in cognitive processes, neuroplastic signaling, and emotional regulation pathways
The information presented below summarizes findings from publicly available scientific literature and is provided solely for educational and scientific reference purposes
